Nolvadex, Tamoxifen Newswire

Nolvadex, Tamoxifen Newswire

Comprehensive Real-Time News Feed for Nolvadex, Tamoxifen (generic).

Results 1 - 7 of 7 in Nolvadex, Tamoxifen (generic)

  1. Atossa's topical breast cancer candidate endoxifen performs well in...Read the original story w/Photo

    Sep 14, 2017 | Seeking Alpha

    Nano cap Atossa Genetics jumps on a more than a 6x surge in volume in response to its announcement of positive results in a 48-subject Phase 1 dose escalation study of topical endoxifen. All objectives were achieved.

    Comment?

  2. Canada Oncology Drugs Market: Help in the Prevention, Diagnosis, and Treatment of CancerRead the original story w/Photo

    Aug 21, 2017 | SBWire

    It includes chemotherapy drugs, hormone therapy drugs such as Tamoxifen , immunotherapy drugs, and other drugs such as bosulif , bosutinib, brentuximab vedotin and brigatinib that are used in the treatment of cancer. According to the CDC, 21.1 million adults were diagnosed with cancer in 2015.

    Comment?

  3. The Unusual Discovery of 10 Commonly Prescribed Medications - Part 2Read the original story w/Photo

    Jun 16, 2017 | Pharmacy Times

    The process of drug discovery and testing can be a long, slow, and painful road. It's estimated that for approximately every 10,000-15,000 new compounds identified, only 5 will be considered safe for testing in human volunteers and 1 will be approved by the FDA.1 Additionally, the journey from preclinical studies to FDA approval can take 10-15 years and range in cost from $800 million to $1.4 billion.

    Comment?

  4. Nonalcoholic Steatohepatitis Market Expected to Register High Revenue Growth Through 2024Read the original story w/Photo

    Feb 22, 2017 | SBWire

    Nonalcoholic Steatohepatitis Market: Overview Nonalcoholic steatohepatitis is liver inflammation and damage caused by a buildup of fat in the liver. It is also known as silent liver disease.

    Comment?

  5. Nonalcoholic Steatohepatitis Market Will Generate New Growth Opportunities by 2020Read the original story w/Photo

    Jan 6, 2017 | SBWire

    Nonalcoholic steatohepatitis is liver inflammation and damage caused by a buildup of fat in the liver. It is also known as silent liver disease.

    Comment?

  6. Global Nonalcoholic Steatohepatitis Market Overview, Scope, Market...Read the original story w/Photo

    Dec 16, 2016 | SBWire

    Nonalcoholic steatohepatitis is liver inflammation and damage caused by a buildup of fat in the liver. It is also known as silent liver disease.

    Comment?

  7. Recent Research: Nonalcoholic Steatohepatitis Market Professional...Read the original story w/Photo

    Dec 15, 2016 | SBWire

    Nonalcoholic steatohepatitis is liver inflammation and damage caused by a buildup of fat in the liver. It is also known as silent liver disease.

    Comment?